Huaren Pharmaceutical Co., Ltd. (300110.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.72B
Enterprise Value4.19B
P/E Ratio-6.42
PEG Ratio-0.12
Price/Sales Ratio2.6
Price/Book Ratio3.66
Enterprise/Revenue3.11
Enterprise/EBITDA-9.73

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.4
Operating Margin-0.38
AD

Management Effectiveness

Return On Assets-0.18
Return On Equity-0.57

Income Statement

Revenue1.32B
Revenue/Share1.03
Gross Profit489.54M
EBITDA-308.5M
Net Income-462.9M
Diluted EPS-0.39

Balance Sheet

Total Cash233.38M
Total Cash/Share0.2
Total Debt855.36M
Total Debt/Equity0.99
Current Ratio0.85
Book Value Per Share0.79

Price History

52-Week Change-24.93
52-Week High3.98
52-Week Low2.41
Moving Average 50 Days2.94
Moving Average 200 Days2.96

Statistics

Average Volume64.56M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split Factor287:250
Last Split DateFebruary 09, 2018
AD